Oncology Specialist at BillionToOne

Houston, Texas, United States

BillionToOne Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, HealthcareIndustries

Requirements

  • Bachelor's Degree or equivalent experience
  • Experience selling diagnostic testing in the oncology field and maintaining a strong network of relationships with oncologists; demonstrated successful sales track record (e.g., award winner - President Club, Chairman Club, Rookie of the Year or equivalent) or experience as a Physicians Assistant (PA), Nurse Practitioner (NP) or Registered Nurse (RN) ordering late stage cancer liquid biopsy tests
  • Understanding of buyer/decision maker types, listening, presentation skills, and ability to assess and respond to customer needs
  • Lives within the defined territory and centrally located to defined accounts
  • Commitment to travel within defined territory
  • Excellent organizational and communication skills (written and verbal) with demonstr

Responsibilities

  • Increasing revenue and driving market development through direct sales to individual Oncologists
  • Creating and implementing a strategic business plan to grow revenue quickly in your geography
  • Sales efforts include effective prospecting and cultivating new business and maintaining key relationships

Skills

Oncology
Molecular Diagnostics
Liquid Biopsy
Cell-free DNA

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$380.2MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive pay
Retirement savings package
Parental leave
Free snacks & lunches
Medical, dental, & vision premiums
On campus perks
Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.
Rapid technological advancements may render their current technology obsolete.
Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.
They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.
Their new Austin facility will create 1,000 jobs, boosting production and local economy.
Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI